Address
OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States
Phone
Website
Industry
Recent investment activity
KANDO id: 29979
Corporate information
Official name
OrbiMed Advisors Limited Liability Company
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR | x |
|---|---|---|---|---|---|---|
| OrbiMed Private Investments VII | 2017 | |||||
| OrbiMed Private Investments VI LP | 2015 | |||||
| Orbimed Global Healthcare Associates Fund LP | Hedge fund | 2014 | ||||
| OrbiMed Global Healthcare Fund LP | Hedge fund | 2014 | ||||
| OrbiMed Global Healthcare Fund Ltd | Hedge fund | 2013 | ||||
| OrbiMed Healthcare Investments Fund (Offshore) LP | 2013 | USD | 29,575,000 | |||
| OrbiMed Private Investments V LP | 2013 | |||||
| OrbiMed Private Investments IV LP | Venture | 2009 | 45.20 % | 2.78 x | ||
| OrbiMed Private Investments III LP | Venture | 2006 | 21.30 % | 2.54 x | ||
| OrbiMed Partners II LP | Hedge fund | 1998 | ||||
| OrbiMed Partners LP | Hedge fund | 1993 | ||||
| OrbiMed Healthcare Investments Trust | ||||||
| OrbiMed Royalty Opportunities II LP |
Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 1 - 50 of 114| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_company.png?itok=-3VkoHwg){kind=icon}
|
Affimed Therapeutics AG | Antibody therapeutics for cancer and inflammatory diseases. | N/A | |||
|
|
Amarin Pharmaceuticals Inc | N/A | ||||
|
|
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | |||
|
|
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series B | |||
|
|
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series C | |||
|
|
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series D | |||
|
|
Aragon Pharmaceuticals Inc | Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company. | N/A | |||
|
Arena Pharmaceuticals Inc | N/A | ||||
|
|
arGEN-X BV | Innovation-driven biopharmaceutical company. | N/A | |||
|
|
Arsanis Biosciences GmbH | N/A | ||||
|
|
Auxilium Pharmaceuticals Inc | N/A | ||||
|
|
Avanir Pharmaceuticals Inc | A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. | N/A | |||
|
|
Beijing East Whale Image Technology Co Ltd (Whale Imaging) | High-tech medical imaging devices company which utilizes the company's unique core competencies | N/A | |||
|
|
Bharat Serums and Vaccines Ltd | Indian bio-pharmaceutical company | N/A | |||
|
|
BioCryst Pharmaceuticals Inc | N/A | ||||
|
|
Biodel Inc | A biopharmaceutical company focused on the development and commercialization of treatments for diabetes | Series B | |||
|
|
Biolex Therapeutics Inc | N/A | ||||
|
|
Bonovo Orthopedics Inc | Provider of orthopedic products to the Chinese healthcare market. | N/A | |||
|
|
Caliper Life Sciences Inc | N/A | ||||
|
|
Cerapedics Inc | N/A | ||||
|
|
Cerenis Therapeutics SA | N/A | ||||
|
|
Cerimon Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing innovative therapeutics to patients with substantial, unmet medical needs. | N/A | |||
|
|
ChemoCentryx Inc | N/A | ||||
|
|
Connetics Corp | N/A | ||||
|
|
Crown Bioscience Inc | A Contractor Research Operation (CRO) company based in Santa Clara, California and Beijing, China | N/A | |||
|
|
DFINE Inc | Mission is to develop and market devices that treat vertebral compression | N/A | |||
|
|
EA Inc | Manufacturer of orthodontics products in China. | N/A | |||
|
|
Ecron Acunova | Provides clinical development services. | N/A | |||
|
|
Eddingpharm | Consumer pharmaceutical products | N/A | |||
|
|
Emphasys Medical | N/A | ||||
|
|
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | Venture | |||
|
|
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | Venture | |||
|
|
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | Venture | |||
|
|
ForteBio Inc | N/A | ||||
|
|
Glaukos Corp | N/A | ||||
|
|
Glaukos Corp | Series D | ||||
|
|
Good Start Genetics Inc | An innovative, molecular diagnostic company that has developed more accurate and comprehensive pre-pregnancy genetic tests | N/A | |||
|
|
Igenica Inc | A monoclonal-antibody discovery and development company | N/A | |||
|
|
Igenica Inc | A monoclonal-antibody discovery and development company | N/A | |||
|
|
Innovative Spinal Technologies Inc | Spine technology company. | Series C | |||
|
|
Insulet Corp | N/A | ||||
|
|
ISIS Pharmaceuticals Inc | N/A | ||||
|
|
Kalidex Pharmaceuticals Inc | Providing next-generation anti-infective therapies to the marketplace | N/A | |||
|
|
Keystone Heart Ltd | Developing cerebral protection devices. | N/A | |||
|
|
KIMS GCC | N/A | ||||
|
|
KIMS India | Asia's leading tertiary care hospitals. | N/A | |||
|
|
Memory Pharmaceuticals Corp | N/A | ||||
|
|
Molecular Staging Inc | Novel technologies company for immunodiagnostics. | N/A | |||
|
|
Orphan Medical Inc | N/A | ||||
|
|
Otic Pharma Ltd | Manufacturer of foam drug delivery system to treat ear disorders. | N/A |
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/_person_0.png?itok=nkWWtsDD){kind=icon}